Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?

BACKGROUND. Despite the advent of new treatment strategies, many patients with diffuse large B-cell lymphoma (DLBCL) relapse or die of the disease. Prospective clinical trials have demonstrated that lenalidomide is an effective and safe treatment option, especially for non-germinal center B-cell (no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Mondello, Patrizia, Steiner, Normann, Willenbacher, Wolfgang, Ferrero, Simone, Ghione, Paola, Marabese, Alessandra, Pitini, Vincenzo, Cuzzocrea, Salvatore, Mian, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Hematologic Malignancies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5016065/
https://ncbi.nlm.nih.gov/pubmed/27382029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados